Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 9† | 1,675† | 1,699† | 1,567† | 1,680† |
| Net profit | -293 | -114 | 5 | -22 | 25† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| SANJIV GOYAL | Executive Director | June 30, 2026 |
| SUSHIL KAPOOR | Executive Director | June 30, 2026 |
| INDU PAL KAUR | Independent Director | June 30, 2026 |
| KULDIP KUMAR BHASIN | Independent Director | June 30, 2026 |
| RUPINDER TEWARI | Independent Director | June 30, 2026 |
| SURULICHAMY SENTHILKUMAR | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
